A Randomized, Placebo-controlled, Double-blind, Multicenter, 12‑Week, 3-Way, Partial-replicate Crossover Pharmacodynamic Study to Assess the Equivalence of Budesonide and Albuterol (BDA) Delivered by MDI HFO Compared with BDA Delivered by MDI HFA in Participants with Asthma.

should be 18years or older with diagnosis of asthma , no asthma related hospitalizations in last past year and systemic steroid usage within past 6 months.